HK1112229A1 - Novel 4-cyano, 4-amino, and 4-aminomethyl derivatives of pyrazolo [1,5- a]pyridines, pyrazolo [1,5-c]pyrimidines and 2h-indazole compounds and 5- cyano, 5-amino, and 5-aminomethyl derivatives of imidazo [1,2-a]pyridines, and imidazo [1,5-a]pyrazines compounds as cyclin dependent kinase inhi - Google Patents
Novel 4-cyano, 4-amino, and 4-aminomethyl derivatives of pyrazolo [1,5- a]pyridines, pyrazolo [1,5-c]pyrimidines and 2h-indazole compounds and 5- cyano, 5-amino, and 5-aminomethyl derivatives of imidazo [1,2-a]pyridines, and imidazo [1,5-a]pyrazines compounds as cyclin dependent kinase inhiInfo
- Publication number
- HK1112229A1 HK1112229A1 HK08107150.3A HK08107150A HK1112229A1 HK 1112229 A1 HK1112229 A1 HK 1112229A1 HK 08107150 A HK08107150 A HK 08107150A HK 1112229 A1 HK1112229 A1 HK 1112229A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compounds
- pyrazolo
- imidazo
- cyano
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71562105P | 2005-09-09 | 2005-09-09 | |
PCT/US2006/034233 WO2007032936A2 (en) | 2005-09-09 | 2006-08-31 | Azafused cyclin dependent kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1112229A1 true HK1112229A1 (en) | 2008-08-29 |
Family
ID=37487994
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK08107150.3A HK1112229A1 (en) | 2005-09-09 | 2008-06-27 | Novel 4-cyano, 4-amino, and 4-aminomethyl derivatives of pyrazolo [1,5- a]pyridines, pyrazolo [1,5-c]pyrimidines and 2h-indazole compounds and 5- cyano, 5-amino, and 5-aminomethyl derivatives of imidazo [1,2-a]pyridines, and imidazo [1,5-a]pyrazines compounds as cyclin dependent kinase inhi |
Country Status (10)
Country | Link |
---|---|
US (3) | US7700773B2 (de) |
EP (1) | EP1931641B1 (de) |
JP (1) | JP2009507843A (de) |
CN (1) | CN101300233A (de) |
AT (1) | ATE478852T1 (de) |
CA (1) | CA2621983A1 (de) |
DE (1) | DE602006016455D1 (de) |
ES (1) | ES2349476T3 (de) |
HK (1) | HK1112229A1 (de) |
WO (1) | WO2007032936A2 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006109867A1 (ja) * | 2005-04-07 | 2006-10-19 | Teijin Pharma Limited | ピラゾロ[1,5-a]ピリジン誘導体またはその医学上許容される塩 |
ATE478852T1 (de) * | 2005-09-09 | 2010-09-15 | Schering Corp | Neue 4-cyano-, 4-amino-, und 4- aminomethylderivative von pyrazoloä1,5- aüpyridinen, pyrazoloä1,5-cüpyrimidinen und 2h- indazolverbindungen und 5-cyano-, 5-amino- und 5- aminomethylderivative von imidazoä1,2-aüpyridinen,und imidazoä1,5-aüpyrazinverbindungen als inhibitoren der cyclinabhänggen kinase |
CN101454314A (zh) | 2006-03-31 | 2009-06-10 | 先灵公司 | 激酶抑制剂 |
NZ596185A (en) * | 2009-04-16 | 2013-01-25 | Ct Nac Investigaciones Oncologicas Cnio | Imidazopyrazines for use as kinase inhibitors |
US9073927B2 (en) | 2010-01-22 | 2015-07-07 | Fundacion Centro Nacional De Investigaciones Oncologicas Carlos Iii | Inhibitors of PI3 kinase |
US20130131057A1 (en) | 2010-05-13 | 2013-05-23 | Centro Nacional De Investigaciones Oncologicas (Cnio | New bicyclic compounds as pi3-k and mtor inhibitors |
EP2651944B1 (de) * | 2010-12-17 | 2015-09-23 | Bayer Intellectual Property GmbH | Substituierte 6-imidazopyrazines zur verwendung als mps-1 und tkk-inhibitoren zur behandlung von hyperproliferativen erkrankungen |
WO2012080236A1 (en) * | 2010-12-17 | 2012-06-21 | Bayer Pharma Aktiengesellschaft | 6-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders |
CA2832310A1 (en) | 2011-04-06 | 2012-10-11 | Bayer Intellectual Property Gmbh | Substituted imidazopyridines and intermediates thereof |
US8883819B2 (en) | 2011-09-01 | 2014-11-11 | Irm Llc | Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension |
KR102427777B1 (ko) | 2012-06-26 | 2022-08-01 | 델 마 파마슈티컬스 | 디안하이드로갈락티톨, 디아세틸디안하이드로갈락티톨, 디브로모둘시톨, 또는 그의 유사체 또는 유도체를 이용하여 유전학적 다형성이 있는 환자에 있어서 티로신-키나아제-억제제 내성 악성종양, ahi1 조절곤란 또는 돌연변이를 치료하는 방법 |
EP2928893A1 (de) * | 2012-12-10 | 2015-10-14 | F. Hoffmann-La Roche AG | Neuartige doppelring-phenylpyridine/-pyrazine zur behandlung von krebs |
CN104837842A (zh) * | 2012-12-10 | 2015-08-12 | 霍夫曼-拉罗奇有限公司 | 新型二环苯基-吡啶/吡嗪用于治疗癌症 |
US9073921B2 (en) | 2013-03-01 | 2015-07-07 | Novartis Ag | Salt forms of bicyclic heterocyclic derivatives |
US11491154B2 (en) | 2013-04-08 | 2022-11-08 | Dennis M. Brown | Therapeutic benefit of suboptimally administered chemical compounds |
CN106164066B (zh) | 2014-02-13 | 2020-01-17 | 因赛特公司 | 作为lsd1抑制剂的环丙胺 |
WO2015123424A1 (en) | 2014-02-13 | 2015-08-20 | Incyte Corporation | Cyclopropylamines as lsd1 inhibitors |
WO2015157955A1 (en) * | 2014-04-17 | 2015-10-22 | Abbvie Inc. | Heterocyclic btk inhibit ors |
US9695167B2 (en) | 2014-07-10 | 2017-07-04 | Incyte Corporation | Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors |
ES2757948T3 (es) | 2015-04-03 | 2020-04-30 | Incyte Corp | Compuestos heterocíclicos como inhibidores LSD1 |
CR20180152A (es) | 2015-08-12 | 2018-08-09 | Incyte Corp | Sales de un inhibidor de lsd1 |
US10968200B2 (en) | 2018-08-31 | 2021-04-06 | Incyte Corporation | Salts of an LSD1 inhibitor and processes for preparing the same |
CA3111977A1 (en) | 2018-09-10 | 2020-03-19 | Mirati Therapeutics, Inc. | Combination therapies |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2126573T3 (es) | 1991-04-22 | 1999-04-01 | Otsuka Pharma Co Ltd | Derivado de pirazol (1,5-a)pirimidina y agente antiinflamatorio que contiene este derivado. |
EP0628559B1 (de) | 1993-06-10 | 2002-04-03 | Beiersdorf-Lilly GmbH | Pyrimidinverbindungen und ihre Verwendung als Pharmazeutika |
US5571813A (en) | 1993-06-10 | 1996-11-05 | Beiersdorf-Lilly Gmbh | Fused pyrimidine compounds and their use as pharmaceuticals |
ATE208776T1 (de) | 1994-06-21 | 2001-11-15 | Otsuka Pharma Co Ltd | Pyrazolo(1,5-a) pyrimidin-derivate |
ATE355841T1 (de) | 1997-12-13 | 2007-03-15 | Bristol Myers Squibb Co | Verwendung von pyrazolo ( 3,4-b) pyridin als cyclin-abhängige kinase hemmer |
US6413974B1 (en) | 1998-02-26 | 2002-07-02 | Aventis Pharmaceuticals Inc. | 6,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines |
DE60004781T2 (de) | 1999-01-11 | 2004-07-08 | Princeton University | Kinase-inhibitoren mit hoher affinität zur ziel detektion und ihre verwendung |
EP1299094A2 (de) * | 2000-06-28 | 2003-04-09 | Bristol-Myers Squibb Company | Selektive androgenrezeptormodulatoren und methoden zu deren identifizierung, entwurf und verwendung |
EE200300041A (et) | 2000-07-26 | 2005-04-15 | Bristol-Myers Squibb Company | Tsükliin-sõltuvate kinaaside N-[5-[[[5-alküül-2-oksasolüül]metüül]tio]-2-tiasolüül]karboksamiidinhibiitorid |
US7067520B2 (en) | 2000-11-17 | 2006-06-27 | Ishihara Sangyo Kaisha, Ltd. | Preventive or therapeutic medicines for diabetes containing fused-heterocyclic compounds or their salts |
CA2432417A1 (fr) | 2000-12-20 | 2002-06-27 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R .A.S.) | Inhibiteurs de kinases dependantes des cylines (cdk) et de la glycogene synthase kinase-3 (gsk-3) |
US6897208B2 (en) | 2001-10-26 | 2005-05-24 | Aventis Pharmaceuticals Inc. | Benzimidazoles |
TWI263640B (en) * | 2001-12-19 | 2006-10-11 | Bristol Myers Squibb Co | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
FR2836915B1 (fr) * | 2002-03-11 | 2008-01-11 | Aventis Pharma Sa | Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant |
GB0218625D0 (en) | 2002-08-10 | 2002-09-18 | Astex Technology Ltd | Pharmaceutical compounds |
NZ539162A (en) | 2002-09-04 | 2006-07-28 | Schering Corp | Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
AR041133A1 (es) | 2002-09-04 | 2005-05-04 | Pharmacopeia Drug Discovery | Pirazolopirimidinas como inhibidores de la quinasa dependientes de la ciclina |
US7074924B2 (en) | 2002-09-04 | 2006-07-11 | Schering Corporation | Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
JP4881558B2 (ja) | 2002-09-04 | 2012-02-22 | シェーリング コーポレイション | サイクリン依存性キナーゼインヒビターとしてのピラゾロピリミジン |
KR20050057072A (ko) | 2002-09-04 | 2005-06-16 | 쉐링 코포레이션 | 사이클린 의존성 키나제 억제제로서의 피라졸로피리미딘 |
AU2003270489A1 (en) * | 2002-09-09 | 2004-03-29 | Cellular Genomics, Inc. | 6-ARYL-IMIDAZO(1,2-a)PYRAZIN-8-YLAMINES, METHOD OF MAKING, AND METHOD OF USE THEREOF |
ES2297203T3 (es) | 2002-09-19 | 2008-05-01 | Schering Corporation | Pirazolopiridinas como inhibidores de quinasas dependientes de ciclina. |
DE60317529T2 (de) | 2002-09-19 | 2008-09-25 | Schering Corp. | Imidazopyridine als hemmstoffe cyclin abhängiger kinasen |
JP2006503838A (ja) | 2002-09-23 | 2006-02-02 | シェーリング コーポレイション | サイクリン依存性キナーゼインヒビターとしての新規イミダゾピラジン |
ATE377600T1 (de) * | 2002-09-23 | 2007-11-15 | Schering Corp | Imidazopyrazine als cdk-inhibitoren |
US7417053B2 (en) * | 2005-04-07 | 2008-08-26 | Teijin Pharma Limited | Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof |
ATE478852T1 (de) * | 2005-09-09 | 2010-09-15 | Schering Corp | Neue 4-cyano-, 4-amino-, und 4- aminomethylderivative von pyrazoloä1,5- aüpyridinen, pyrazoloä1,5-cüpyrimidinen und 2h- indazolverbindungen und 5-cyano-, 5-amino- und 5- aminomethylderivative von imidazoä1,2-aüpyridinen,und imidazoä1,5-aüpyrazinverbindungen als inhibitoren der cyclinabhänggen kinase |
-
2006
- 2006-08-31 AT AT06802808T patent/ATE478852T1/de not_active IP Right Cessation
- 2006-08-31 DE DE602006016455T patent/DE602006016455D1/de active Active
- 2006-08-31 ES ES06802808T patent/ES2349476T3/es active Active
- 2006-08-31 US US11/514,548 patent/US7700773B2/en not_active Expired - Fee Related
- 2006-08-31 CN CNA2006800412880A patent/CN101300233A/zh active Pending
- 2006-08-31 CA CA002621983A patent/CA2621983A1/en not_active Abandoned
- 2006-08-31 JP JP2008530115A patent/JP2009507843A/ja active Pending
- 2006-08-31 EP EP06802808A patent/EP1931641B1/de active Active
- 2006-08-31 WO PCT/US2006/034233 patent/WO2007032936A2/en active Application Filing
-
2008
- 2008-06-27 HK HK08107150.3A patent/HK1112229A1/xx not_active IP Right Cessation
-
2010
- 2010-02-16 US US12/706,551 patent/US20100143384A1/en not_active Abandoned
- 2010-02-17 US US12/706,814 patent/US20100137326A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2007032936A2 (en) | 2007-03-22 |
ES2349476T3 (es) | 2011-01-03 |
US20100137326A1 (en) | 2010-06-03 |
DE602006016455D1 (de) | 2010-10-07 |
US20100143384A1 (en) | 2010-06-10 |
CA2621983A1 (en) | 2007-03-22 |
EP1931641A2 (de) | 2008-06-18 |
EP1931641B1 (de) | 2010-08-25 |
CN101300233A (zh) | 2008-11-05 |
JP2009507843A (ja) | 2009-02-26 |
ATE478852T1 (de) | 2010-09-15 |
US20070066621A1 (en) | 2007-03-22 |
US7700773B2 (en) | 2010-04-20 |
WO2007032936A3 (en) | 2007-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1112229A1 (en) | Novel 4-cyano, 4-amino, and 4-aminomethyl derivatives of pyrazolo [1,5- a]pyridines, pyrazolo [1,5-c]pyrimidines and 2h-indazole compounds and 5- cyano, 5-amino, and 5-aminomethyl derivatives of imidazo [1,2-a]pyridines, and imidazo [1,5-a]pyrazines compounds as cyclin dependent kinase inhi | |
TW200745123A (en) | Pyrazolopyrimidines as protein kinase inhibitors | |
MX2009011355A (es) | Nuevas pirazolopirimidinas como inhibidores de quinasas dependientes de ciclinas. | |
MY149044A (en) | Pyrazolopyrimidines - derivatives as cyclin dependent kinase inhibitors | |
HK1112233A1 (en) | Pyrazolopyrimidines as cyclin dependent kinase inhibitors for the treatment of cancer | |
TW200745128A (en) | Pyrazolopyrimidines as protein kinase inhibitors | |
TW200407322A (en) | Novel imidazopyridines as cyclin dependent kinase inhibitors | |
TW200745127A (en) | Pyrazolopyrimidines as protein kinase inhibitors | |
WO2007044449A3 (en) | Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors | |
MY139336A (en) | N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors | |
MX2009003733A (es) | Pirazolopirimidinas como inhibidores de quinasas dependientes de ciclina. | |
WO2007044401A3 (en) | Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors | |
BRPI0314001B8 (pt) | pirazolopirimidinas como inibidores de cinase dependente de ciclina e composição farmacêutica compreendendo as mesmas | |
WO2007058873A3 (en) | Imidazopyrazines as cyclin depentend kinase inhibitors | |
MY137843A (en) | Pyrazolopyrimidines as cyclin dependent kinase inhibitors | |
TW200420564A (en) | Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors | |
MY134589A (en) | Imidazopyrazines as cyclin dependent kinase inhibitors | |
WO2008045267A3 (en) | Pyrazolopyrimidines as cyclin dependent kinase inhibitors | |
MX2009003734A (es) | Pirazolopirimidinas como inhibidor de cinasas dependientes de ciclina. | |
WO2004026310A8 (en) | Novel imidazopyrazines as cyclin dependent kinase inhibitors | |
IL182893A0 (en) | PYRAZOLO-[1,5-a] PYRIMIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
MY188335A (en) | Imidazotriazines and imidazopyrimidines as kinase inhibitors | |
UA95230C2 (ru) | ЗАМЕЩЕННЫЕ ТЕТРАГИДРОПИРИМИДО[4,5-d]ПИРИМИДИНЫ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ ИХ, И ИХ ПРИМЕНЕНИЕ | |
MX2010006748A (es) | Pirazolo[1,5-a]pirimidinas utiles como inhibidores de jak2. | |
MY136840A (en) | Pyrazolopyridines as cyclin dependent kinase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20140831 |